... Biotech|. Share This Story, Choose Your Platform! FacebookTwitterReddit ... Grand Rapids Fintech Provider Purchased By San Antonio Services Company ...
News
- Ford Fund, Nebraska Mobility Provider To Bridge Transportation Gaps In Detroit Healthcare
- Intensity Therapeutics Presents Positive INT230-6 Data in Patients with Early-Stage Breast ...
... San Antonio Breast Cancer Symposium (SABCS). Information on the ... Intensity Therapeutics is a late-stage biotechnology company that applies novel ...
- Genentech's Kadcyla Is the First Targeted Therapy to Show Significant Overall Survival ... - BioSpace
Full data are being presented as an oral presentation at the 2023 San Antonio Breast Cancer Symposium on Friday, December 8. Kadcyla is approved ...
- Dato-DXd Deemed New Treatment Option for HR+, HER2- Advanced Breast Cancer
... San Antonio Breast Cancer Symposium 2023. Researchers found that Dato ... Some study authors declared affiliations with biotech, pharmaceutical, and/or ...
- Some breast cancer survivors may safely de-escalate mammography three years after surgery
Biomedical technology · Cardiology · Dentistry · Diabetes · Diseases ... San Antonio Breast Cancer Symposium, held December 5–9, 2023. Both U.S. ...